Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD

Abstract

Extracorporeal photopheresis (ECP) was given to 23 patients with steroid-refractory acute GVHD (aGVHD, grade II (n=10), III (n=7) or IV (n=6)). The median duration of ECP was 7 months (1–33) and the median number of ECP cycles in each patient was 10. Twelve patients (52%) had complete responses. Eleven patients (48%) survived and 12 died, 10 of GVHD with or without infections and two of leukaemia relapse. The average grade of GVHD was reduced from 2.8 (on the first day of ECP) to 1.4 (on day +90 from ECP) (P=0.08), and the average dose of i.v. methylprednisolone from 2.17 to 0.2 mg/kg/d (P=0.004). Complete responses were obtained in 70, 42 and 0% of patients, respectively, with grades II, III and IV aGVHD; complete responses in the skin, liver and gut were 66, 27 and 40%. Patients treated within 35 days from onset of aGVHD had higher responses (83 vs 47%; P=0.1). A trend for improved survival was seen in grade III–IV aGVHD treated with ECP as compared to matched controls (38 vs 16%; P 0.08). ECP is a treatment option for patients with steroid refractory aGVHD and should be considered early in the course of the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Ferrara JLM, Deeg HJ . Graft-versus-host-disease. N Engl J Med 1991; 324: 667–674.

    Article  CAS  PubMed  Google Scholar 

  2. Anasetti C, Hansen JA . Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Tranfusion Sci 1994; 15: 221–230.

    Article  CAS  Google Scholar 

  3. Van Lint MT, Uderzo C, Locasciulli A, Majolino I, Scime R, Locatelli R et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomised trial from the Italian group for Bone Marrow Transplantation. Blood 1998; 92: 2288–2293.

    CAS  PubMed  Google Scholar 

  4. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald JB et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464–1472.

    CAS  PubMed  Google Scholar 

  5. Van Lint MT, Milone G, Leotta S, Uderzo C, Scimèe R, Dallorso S et al. Treatment of acute graft-versus-hot disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-tymocyte globulin. Blood 2006; 107: 4177–4182.

    Article  CAS  PubMed  Google Scholar 

  6. Martin PJ, Shoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB et al. A retrospective analysis of therapy for acute graft-versus-host-disease: secondary treatment. Blood 1991; 62: 626–631.

    Google Scholar 

  7. Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  PubMed  Google Scholar 

  8. Bacigalupo A, Palandri F . Management of acute graft-versus-host disease (GvHD). Hematol J 2004; 5: 189–196.

    Article  CAS  PubMed  Google Scholar 

  9. Rossetti F, Dall'Amico R, Provetti G, Massina C, Montini G, Dini G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. BMT 1996; 18 (Suppl 2): S175–S181.

    Google Scholar 

  10. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118–127.

    Article  CAS  PubMed  Google Scholar 

  11. Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). BMT 1999; 23: 881–887.

    CAS  Google Scholar 

  12. Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giorgiani G et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001; 41: 1299–1305.

    Article  CAS  PubMed  Google Scholar 

  13. Apisarnthanarax N, Donato M, Korbling M, Couriel D, Gajewski J, Giralt S et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. BMT 2003; 31: 459–465.

    CAS  Google Scholar 

  14. Rubegni P, Cuccia A, Sbano P, Cevenini G, Carcagni MR, D'Ascenzo G et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005; 130: 271–275.

    Article  CAS  PubMed  Google Scholar 

  15. Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Deméocq F . Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apher Sci 2003; 28: 71–80.

    Article  PubMed  Google Scholar 

  16. Greinix HT, Volc-Platzer B, Rabitsh W, Gmeinhart B, Guevara-Pineda C, Kalhs P et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998; 92: 3098–3104.

    CAS  PubMed  Google Scholar 

  17. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematol 2006; 91: 405–408.

    Google Scholar 

  18. Russel-Jones R . Shedding light on photopheresis. Lancet 2001; 357: 820.

    Article  Google Scholar 

  19. Steinman RM, Turley S, Mellman I, Inaba K . The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411–416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Albert ML . Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004; 4: 223–231.

    Article  CAS  PubMed  Google Scholar 

  21. Greinix HT, Sociè G, Bacigalupo A, Holler E, Edinger MG, Apperley JF et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Meeting report. 2006; 38: 265–273.

    Article  CAS  PubMed  Google Scholar 

  22. Schwarz T . Regulatory T cells induced by ultraviolet radiation. Int Arch Allergy Immunol 2005; 137: 187–193.

    Article  PubMed  Google Scholar 

  23. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79: 846–850.

    Article  PubMed  Google Scholar 

  24. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induced antigen-specific regulatory T cells. J Immunol 2005; 174: 5968–5976.

    Article  CAS  PubMed  Google Scholar 

  25. Perrit D . Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood marrow Transplant 2006; 12: 7–12.

    Article  Google Scholar 

  26. Gorgun G, Miller KB, Foss FM . Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100: 941–947.

    Article  CAS  PubMed  Google Scholar 

  27. Suchin KR, Cassin M, Washko R, Nahass G, Berkson M, Stouch B et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999; 41: 980–986.

    Article  CAS  PubMed  Google Scholar 

  28. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee S et al. National Institute of Health consensus development project on criteria for clinical trias in chronic graft versus host disease: I. Diagnosis and staging working report. Biol Blood Marrow Transplant 2005; 11: 945.

    Article  PubMed  Google Scholar 

  29. Marshall SR . Technology insight: ECP for the treatment of GvHD- can we offer selective immune control without generalized immunosuppression? Nat Clin Pract 2006; 3: 302–314.

    Article  CAS  Google Scholar 

  30. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N.Engl J Med 1987; 316: 297–303.

    Article  CAS  PubMed  Google Scholar 

  31. Dall'Amico R, Murer L . Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Transfus Apher Sci 2002; 26: 197–204.

    Article  PubMed  Google Scholar 

  32. Menkes CJ, Andreu G, Heshmati F, Hilliquin P . Extracorporeal photochemotherapy. Br J Rheumatol 1992; 31: 789–790.

    Article  CAS  PubMed  Google Scholar 

  33. Knobler RM . Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations. Semin Immunopathol 1994; 16: 323–325.

    CAS  Google Scholar 

  34. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Witmer WK et al. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990; 112: 303–305.

    Article  CAS  PubMed  Google Scholar 

  35. Dall'Amico R, Messina C . Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002; 6: 296–304.

    Article  CAS  PubMed  Google Scholar 

  36. Dall'Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997; 97: 848–854.

    Article  CAS  PubMed  Google Scholar 

  37. Lim H W, Eldelson RL . Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9: 1117–1126.

    Article  PubMed  Google Scholar 

  38. Perseghin P, Dassi M, Balduzzi A, Rovelli A, Bonanomi S, Uderzo C . Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft vs host disease: comparison between Cobe Spectra version 4.7 and 6.0 (Auto PBSC). J Clin Apher 2002; 17: 65–71.

    Article  PubMed  Google Scholar 

  39. Garban F, Drillat P, Makowski C, Jacob MC, Richard MJ, Favrot M et al. Extracorporeal chemophototherapy for the treatment of graft versus host disease: hematologic consequences of short term, intensive courses. Haematologica 2005; 1096: 101.

    Google Scholar 

Download references

Acknowledgements

This work was partly supported by Associazione Italiana Ricerca contro il Cancro (AIRC) Milano, CARIGE, and Fondazione Ricerca per Trapianto Midollo Osseo, Genova.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Bacigalupo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perfetti, P., Carlier, P., Strada, P. et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 42, 609–617 (2008). https://doi.org/10.1038/bmt.2008.221

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.221

Keywords

This article is cited by

Search

Quick links